Home    Back

 Drug    DrugBank | All Description Patterns

   e.g. "Sirolimus", "Adalimumab"

A    B    C    D    E    F    G    H     I     J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    other

40 / 12,170 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   Drug (Description in trials)   DrugBank   KEGG DRUG *   KEGG GENES * 
 [Number of genes] 		  KEGG PATHWAY 
 [Number of pathways] 		  Disease ID * 
 [Number of diseases] 
 1   18 fdg   -   -   -   -   [1]
145 
 2   Acetate   Acetate   -   -   -   [40]
1,
2,
6,
10,
13,
35,
40,
46,
49,
51,
60,
64,
70,
71,
73,
75,
76,
78,
81,
83,
85,
86,
88,
90,
96,
97,
113,
145,
156,
162,
171,
206,
222,
224,
225,
235,
265,
288,
298,
299 
 3   Acth   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [5]
13,
66,
145,
193,
222 
 4   Adrenocorticotropin   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
145 
 5   Adrenocorticotropin hormone   Corticotropin   D00146   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
145 
 6   Cannabidiol   Cannabidiol   D10915   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [13]
6,
13,
46,
95,
96,
97,
140,
144,
145,
157,
158,
193,
271 
 7   Cannabidiol oral solution   Cannabidiol   D10915   [2] CNR1, CNR2   [4] Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis   [4]
140,
144,
145,
193 
 8   Cosyntropin   Tetracosactide   D00284   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [3]
83,
113,
145 
 9   Cosyntropin injectable suspension 1 mg/ml + vigabatrin   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
145 
 10   Cosyntropin injectable suspension, 1 mg/ml   Tetracosactide   D00284   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [1]
145 
 11   Decortin   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [5]
46,
96,
97,
113,
145 
 12   Decortin h   Prednisone   D00473   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
145 
 13   Ganaxolone   Ganaxolone   D04300   [16] GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ   [7] GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction   [3]
145,
152,
206 
 14   Gwp42003-p   -   -   -   -   [5]
140,
144,
145,
156,
158 
 15   Intravenous methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
145 
 16   Jbpos0101   -   -   -   -   [1]
145 
 17   M071754   -   -   -   -   [1]
145 
 18   Methylprednisolone   Methylprednisolone   D00407, D00751, D00979, D05000, D05001, D05002   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [36]
2,
13,
25,
26,
35,
38,
39,
40,
41,
42,
43,
45,
46,
49,
50,
51,
60,
63,
64,
65,
66,
83,
84,
86,
96,
97,
145,
164,
220,
222,
224,
271,
283,
284,
285,
296 
 19   Modified atkins diet   -   -   -   -   [2]
145,
157 
 20   Null   -   -   -   -   [17]
6,
13,
14,
15,
28,
37,
46,
49,
51,
63,
86,
90,
96,
97,
107,
145,
271 
 21   Oral pednisolone   -   -   -   -   [1]
145 
 22   Oral prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [2]
49,
145 
 23   Prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [38]
11,
13,
25,
26,
35,
38,
39,
41,
43,
44,
45,
46,
49,
50,
51,
56,
60,
61,
63,
64,
65,
66,
75,
81,
84,
85,
95,
96,
97,
113,
145,
162,
222,
269,
271,
296,
299,
300 
 24   Pyridoxine   Pyridoxine   D02179, D08454   -   -   [2]
93,
145 
 25   Pyridoxine plus prednisolone   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
145 
 26   Radiprodil   Radiprodil   -   -   -   [1]
145 
 27   Sabril   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
145 
 28   Sabril granules for oral use   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
145 
 29   Sabril sachets   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
145 
 30   Sabrilex   -   -   -   -   [1]
145 
 31   Sabril®   -   -   -   -   [1]
145 
 32   Soluble prednisolone tablets   Prednisolone   D00472, D00980, D00981, D00982, D01239, D01998, D02156, D03301   [1] NR3C1   [1] Neuroactive ligand-receptor interaction   [1]
145 
 33   Spt3162   -   -   -   -   [1]
145 
 34   Synacthen depot   Tetracosactide   D00284   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [2]
83,
145 
 35   Tetracosactide   Tetracosactide   D00284   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [4]
83,
113,
145,
222 
 36   Tetracosactide acetate   Tetracosactide   D00284   [1] MC2R   [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway   [2]
83,
145 
 37   Vgb-st   -   -   -   -   [1]
145 
 38   Vgb-st soluble tablets   -   -   -   -   [1]
145 
 39   Vigabatrin   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [2]
145,
158 
 40   Vigabatrin: vigabatrin new st formulation then sabril®   Vigabatrin   D00535   [1] ABAT   [7] Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism   [1]
145 

Back to top